[Effects of calcium antagonists on isolated myocardial tissue and their molecular mechanism of action].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy / Q000378:metabolism; D001283:Atrioventricular Node / Q000187:drug effects / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004594:Electrophysiology; D006801:Humans; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D012849:Sinoatrial Node / Q000187:drug effects / Q000502:physiology; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D007473:Ion Channels; D014700:Verapamil
Die Wirkungen von Calciumantagonisten auf isoliertes Myokardgewebe und ihre molekularen Wirkmechanismen.